- Report
- January 2024
- 728 Pages
Global
€1784EUR$2,086USD£1,500GBP
- Report
- June 2022
- 275 Pages
Global
From €684EUR$800USD£575GBP
- Report
- May 2024
- 243 Pages
Global
From €4380EUR$4,950USD£3,813GBP
- Report
- July 2021
- 490 Pages
Global
From €1784EUR$2,086USD£1,500GBP

Graphene Quantum Dots (GQDs) are a type of nanomaterial composed of carbon atoms arranged in a two-dimensional honeycomb lattice. GQDs have unique optical, electrical, and chemical properties that make them attractive for use in biotechnology applications. GQDs can be used to detect and monitor biological molecules, such as proteins, DNA, and enzymes, as well as to deliver drugs and other therapeutic agents to specific cells. GQDs can also be used to create biosensors and bioelectronic devices, which can be used to detect and monitor changes in biological systems.
GQDs are being developed for a variety of biotechnology applications, including drug delivery, biosensing, and bioelectronics. GQDs are also being explored for use in medical diagnostics, tissue engineering, and regenerative medicine.
Companies in the GQD market include Graphenea, Graphene Platform, Graphene Square, Graphene Laboratories, Graphene 3D Lab, Graphene NanoChem, Graphene Biosciences, Graphene Technologies, and Graphenea Technologies. Show Less Read more